Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease.
Wada N, Uojima H, Satoh T, Okina S, Iwasaki S, Shao X, Takiguchi H, Arase Y, Itokawa N, Atsukawa M, Miyazaki K, Hidaka H, Kako M, Kagawa T, Iwakiri K, Horie R, Suzuki T, Koizumi W.
Wada N, et al. Among authors: okina s.
Dig Dis. 2021;39(3):234-242. doi: 10.1159/000510692. Epub 2020 Aug 6.
Dig Dis. 2021.
PMID: 32759604
Free PMC article.
Clinical Trial.